|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860.00 KRW | +0.21% |
|
-8.82% | -28.74% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 2020-03-25 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 2025-03-26 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 2024-03-28 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 2023-03-29 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.21% | -8.82% | -52.02% | - | 74.93M | ||
| -1.13% | +7.89% | +33.13% | +334.32% | 33.14B | ||
| -0.54% | -4.41% | -2.84% | +9.21% | 20.98B | ||
| -1.20% | -1.93% | -24.93% | -44.26% | 6.95B | ||
| +3.76% | -1.68% | +0.96% | +72.58% | 4.23B | ||
| +2.20% | +4.39% | +14.81% | +49.81% | 2.9B | ||
| -6.08% | -7.51% | -17.28% | +799.68% | 1.75B | ||
| +0.12% | -2.61% | -8.65% | -66.59% | 1.68B | ||
| +7.62% | -0.81% | +44.44% | -24.96% | 1.65B | ||
| -1.58% | -0.07% | +12.90% | -4.65% | 1.58B | ||
| Average | +0.37% | -1.25% | +0.05% | +125.01% | 7.49B | |
| Weighted average by Cap. | -0.32% | +1.00% | +12.77% | +169.10% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















